LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />BERENBERG CUTS SSE PRICE TARGET TO 1320 (1570) PENCE - 'HOLD' <br />----------<br />BERENBERG CUTS REED ELSEVIER TO 'HOLD' ('BUY Read More
LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Prudential</strong> PLC reported a sharp fall in 2013 pretax profits due to short-term fluctuations on investment returns, but its clo Read More
LONDON (Alliance News) - Share are lower at the open Wednesday, following Asian and US markets.<br /><br />Just after the open, insurer<strong> Prudential</strong> declared a 15% dividend increase for 2013. CEO Tidjane Thiam promised "more of the same, just better". It also announced an expand Read More
LONDON (Alliance News) - AstraZeneca PLC said Wednesday that it will book a USD275 million write down in the first quarter of 2013, as it announced the sale of its Alderley Park Site in Cheshire to Manchester Science Parks. The sale is part of AstraZeneca's plan to establish a new global re Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />DEUTSCHE BANK CUTS ROLLS-ROYCE PRICE TARGET TO 860 (1090) PENCE - 'SELL'<br />----------<br />MERRILL LYNCH Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />UBS RAISES SHIRE PRICE TARGET TO 3450 (3180) PENCE - 'NEUTRAL'<br />----------<br />UBS RAISES ASTRAZE Read More
LONDON (Alliance News) - Shares have rebound at the open Tuesday, amid reports that Russian President Vladimir Putin has order troops near the Ukraine back to their bases. <br /><br />Miner <strong>Fresnillo</strong> is down 6.8% at the open as it reported profit more than halved in 2013, thou Read More
LONDON (Alliance News) - Stocks have tumbled across the world, while gold and oil prices have jumped sharply, after Russia moved over the weekend to take control of the Crimea, prompting fears that Ukraine could end up going to war with its bigger neighbour.<br /><br />The oil price has hit a Read More
LONDON (Alliance News) - Stock have tumbled across the world, while gold and oil prices have jumped sharply, after Russia moved over the weekend to take control of the Crimea, prompting fears that Ukraine could end up going to war with its bigger neighbour.<br /><br />The oil price has hit a 2 Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br /><br />-------<br /><br />Increasing geopolitical tension following Russia's decision to mobilize its troops in the Crimea region of Ukraine over the weekend has p Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>AstraZeneca</strong> PLC said the US Food and Drug Administration has approved its Bydureon Pen injectable suspension treatment for type Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />BERNSTEIN CUTS RSA INSURANCE PRICE TARGET TO 115 (130) PENCE - 'OUTPERFORM' <br />----------<br />CITIGROUP CUTS RSA INSURANCE P Read More
LONDON (Alliance News) - AstraZeneca PLC Monday said the US Food and Drug Administration has approved its Bydureon Pen injectable suspension treatment for type 2 diabetes as an adjunct to diet and exercise to improve glycaemic control in adults. In a statement, the drugs giant said that Byd Read More
LONDON (Alliance News) - AstraZeneca PLC Tuesday said the US Food and Drug Administration has approved orphan drug MYALEPT as a treatment for fat tissue loss in a rare group of syndromes known as lipodystrophy. The pharma company said the approval is for MYALEPT as an adjunct to diet as rep Read More
LONDON (Alliance News) - UK stocks have struggled to get off the ground Wednesday, closing broadly unchanged despite some impressive individual stock performances. The FTSE 100 initially opened higher, continuing a rally that has seen the index retrace most of January's losses. However, after bre Read More